- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/20 - Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
Patent holdings for IPC class C07D 217/20
Total number of patents in this class: 82
10-year publication summary
4
|
3
|
0
|
2
|
2
|
3
|
4
|
7
|
4
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Mallinckrodt LLC | 132 |
11 |
SpecGx LLC | 188 |
8 |
Chemagis Ltd. | 33 |
4 |
Dermavant Sciences GmbH | 77 |
4 |
Bausch + Lomb Ireland Limited | 695 |
4 |
Takeda Pharmaceutical Company Limited | 2708 |
2 |
Academia Sinica | 940 |
2 |
Analytecon SA | 2 |
2 |
City of Hope | 994 |
2 |
Cornell University | 3307 |
2 |
Mallinckrodt Inc. | 169 |
2 |
Recordati Industria Chimica e Farmaceutica S.p.A. | 54 |
2 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 829 |
2 |
Taipei Medical University | 194 |
2 |
Taisho Pharmaceutical Co., Ltd. | 875 |
2 |
Idorsia Pharmaceuticals Ltd. | 352 |
2 |
Novartis Pharmaceuticals Corporation | 51 |
1 |
The Regents of the University of California | 19961 |
1 |
University of Florida Research Foundation, Inc. | 4035 |
1 |
Duke University | 3069 |
1 |
Other owners | 25 |